CLINICALLY IMPORTANT BACTERIAL INFECTIONS IN CIRRHOSIS
https://doi.org/10.51523/2708-6011.2011-8-3-8
Abstract
Bacterial infections are a frequent and severe complication of cirrhosis that may present on admission or develop during hospitalization in 15-35 % of hospitalized cirrhotic patients. The most frequent infective complications include spontaneous bacterial peritonitis, urinary tract infections, pneumonia and bacteremia. Patients with cirrhosis have of various facilitating mechanisms such as changes in the reticuloendothelial system, decreased opsonic activity of the ascitic fluid, neutrophil leukocyte dysfunction. Up to 25 % of cases of death in cirrhotic patients are related to bacterial infections. This article aims to provide a brief overview of the epidemiology, pathogenesis, treatment and prophylaxis of bacterial infection in cirrhosis.
References
1. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis / A. Pardo [et al.] // Hepatology. - 2000. - Vol. 31. - P. 858-863.
2. Garsia-Tsao, G. Bacterial infections in cirrhosis: treatment and prophylaxis / G. Garsia-Tsao // J. Hepatol. - 2005. - Vol. 42. - P. 85-92.
3. Sepsis in cirrhosis: Report on the 7th meeting of the international ascites club / F. Wong [et al.]. On behalf the International Ascites Club // Gut. - 2005. - Vol. 54. - P. 718-725.
4. Brann, O. S. Infectious complications of cirrhosis / O. S. Brann // Current Gastroenterology Reports. - 2001. - Vol. 3. - P. 285-292.
5. Christou, L. Bacterial infection-related morbidity and mortality in cirrhosis / L. Christou, G. Pappas, M. E. Falagas // The American Journal of Gastroenterology. - 2007. - Vol. 102. - P. 1510-1517.
6. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease / C. Fiuza [et al.] // The Journal of Infectious Diseases. - 2000. - Vol. 182. - P. 526-533.
7. Tandon, P. Bacterial infections, sepsis, and multiorgan failure in cirrhosis / P. Tandon, G. Garsia-Tsao // Seminars in liver disease. - 2008. - Vol. 28, № 1. - P. 36-42.
8. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage / A. Rimola [et al.] // Hepatology. - 1985. - Vol. 5. - P. 463-467.
9. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage / G. Soriano [et al.] //Gastroenterology. - 1992. - Vol. 103. - P. 1267-1272.
10. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage / M. Blaise [et al.] // Hepatology. - 1994. - Vol. 20. - P. 34-38.
11. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study / B. Bernard [et al.] // Gastroenterology. - 1995. - Vol. 108. - P. 1828-1834.
12. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection / A. Pauwels [et al.] // Hepatology. - 1996. - Vol. 24. - P. 802-806.
13. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding / W. J. Hsieh [et al.] // Am J Gastroenterol. - 1998. - Vol. 93. - P. 962-966.
14. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage/ J. Goulis [et al.] // Hepatology. - 1998. - Vol. 27. - P. 1207-1212.
15. Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis / O. Riggio [et al.] // World J. Gastroenterol. - 2008. - Vol. 14. - P. 5689-5694.
16. Gut flora and bacterial translocation in chronic liver disease / J. Almelda [et al.] // World J. Gastroenterol. - 2006. - Vol. 12. - P. 1493-1502.
17. Risk of first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels / C. Guarner [et al.] // Gastroenterology. - 1999. - Vol. 117. - P. 414-419.
18. Koulaouzidis, A. Spontaneous bacterial peritonitis / A. Koulaouzidis, S. Bhat, A. A. Saeed // World J. Gastroenterol. - 2009. - Vol. 15. - P. 1042-1049.
19. Rimola, A. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document / A. Rimola [et al.] / International Ascites Club. // J. Hepatol. - 2000. - Vol. 32. - P. 142-153.
20. WGO-OMGE Practice Guideline: Condition: Management of ascites complicating cirrhosis in adults // (c)http://www.omge.org.
21. Силивончик, Н. Н. Лихорадка, лейкоцитоз и бактериальные инфекции при циррозе печени / Н. Н. Силивончик // Здравоохранение. - 2009. - № 2. - С. 49-52.
22. Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis / S. Angeloni [et al.] // Am J. Gastroenterol. - 2003. - Vol. 98. - P. 1844-1848.
23. Cereto, F. Validation of automated blood cell counters for the diagnosis of spontaneous bacterial peritonitis / F. Cereto, J. Genescà, R. Segura // Am J Gastroenterol. - 2004. - Vol. 99. - P. 1400.
24. Патент РФ 2002122771/15. Способ определения инфицированного выпота брюшной полости и способ лечения заболеваний, сопровождающихся выпотом в брюшную полость / М. Д. Ардатская, О. Н. Минушкин, Н. С. Иконников // Приоритет от 26.08.2002 г.
25. Патент РФ №97117426/14 (018498). Способ выявления возбудителя инфекционного процесса в стерильных биологических средах макроорганизма / Г. А. Осипов, Н. В. Белобородова // Приоритет от 21.10.97 г.
26. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips / Thévenot, T. [et al.] // Eur. J Gastroenterol Hepatol. - 2004. - Vol. 6 (16). - Р. 579-583.
27. Nobre, S. R. Value of reagent strips in the rapid diagnosis of spontaneous bacterial peritonitis / S. R. Nobre, J. E. Cabral, C. Sofia // Hepatogastroenterology. - 2008. - Vol. 55(84). - Р. 1020-1023.
28. Runyon, B. A. AASLD Practice Guidelines: Management of adult patients with ascites due to cirrhosis / B. A. Runyon // Hepatology. - 2004. - Vol. 39. - P. 1-16.
29. Efficacy and safety of recombinant human activated protein C for severe sepsis / G. R. Bernard [et al.] // N Engl J Med. - 2001. - Vol. 344. - P. 699-709.
30. Activation of endothelial cell protease activated receptor 1 by the protein C pathway / M. Riewald [et al] // Science. - 2002. - Vol. 296. - Vol. 1880-1882.
31. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding / S. Vivas [et al.] // Dig Dis Sci. - 2001. - Vol. 46. - P. 2752-2757.
32. Foreman, M. G. Cirrhosis as a risk factor for sepsis and death: analysis of the national hospital discharge survey / M. G. Foreman, D. M. Mannino, M. Moss // Chest. - 2003. - Vol. 124. - P. 1016-1020.
33. Yang, Y. Y. Bacterial infections in patients with cirrhosis / Y. Y. Yang, H. C. Lin // J. Chin. Med. Assoc. - 2005. - Vol. 68(10). - P. 447-451.
34. Use of Reagent Strips for the Rapid Diagnosis of Spontaneous Bacterial Empyema / J. Castellote [et al.] // Journal of Clinical Gastroenterology. - 2005. - Vol. 39(4). - P. 278-281.
35. Chen, T. A. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax / T. A. Chen, G. H. Lo, K. H. Lai // J Chin Med Assoc. - 2003. - Vol. 66. - P. 579-586.
Review
For citations:
Gavrilenko D.I. CLINICALLY IMPORTANT BACTERIAL INFECTIONS IN CIRRHOSIS. Health and Ecology Issues. 2011;(3):44-50. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-3-8
Views: 276
Email this article 